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Abstract
Introduction Patients triaged to tertiary care centers frequently
undergo rotary-wing transport and may be exposed to additional
risk for adverse events. The incidence of physiologic adverse
events and their predisposing factors in mechanically ventilated
patients undergoing aeromedical transport are unknown.
Methods We performed a retrospective review of flight records
of all interfacility, rotary-wing transports to a tertiary care,
university hospital during 2001 to 2003. All patients receiving
mechanical ventilation via endotracheal tube or tracheostomy
were included; trauma, scene flights, and fixed transports were
excluded. Data were abstracted from patient flight and hospital
records. Adverse events were classified as either major (death,
arrest, pneumothorax, or seizure) or minor (physiologic
decompensation, new arrhythmia, or requirement for new
sedation/paralysis). Bivariate associations between hospital and
flight characteristics and the presence of adverse events were
examined.
Results Six hundred eighty-two interfacility flights occurred
during the period of review, with 191 patients receiving
mechanical ventilation. Fifty-eight different hospitals transferred
patients, with diagnoses that were primarily cardiopulmonary
(45%) and neurologic (37%). Median flight distance and time
were 42 (31 to 83) km and 13 (8 to 22) minutes, respectively.
No major adverse events occurred during flight. Forty patients
(22%) experienced a minor physiologic adverse event.
Vasopressor requirement prior to flight and flight distance were
associated with the presence of adverse events in-flight (P <
0.05). Patient demographics, time of day, season, transferring
hospital characteristics, and ventilator settings before and
during flight were not associated with adverse events.
Conclusion Major adverse events are rare during interfacility,
rotary-wing transfer of critically ill, mechanically ventilated
patients. Patients transferred over a longer distance or
transferred on vasopressors may be at greater risk for minor
adverse events during flight.
Introduction
Aeromedical transport is widely used to transport critically ill
patients between facilities. Patients may be transferred to
receive a higher intensity of care, for specific procedures, or to
maintain continuity between patients and clinicians familiar
with their care [1]. Transferred patients may represent up to
20% of the admissions in tertiary care intensive care units
(ICUs), are known to have a higher severity of illness com-
pared with other ICU patients, and have worse-than-expected
ICU outcomes [2-4].
Interhospital transport of severely ill patients is not without risk
[5,6]. In prior heterogeneous cohorts of patients undergoing
interfacility transfer, adverse events have occurred in up to
34% of patients [7]. Air transport may introduce even more
risk, due to patient anxiety [8], movement of patients in smaller
confines, or difficulty in performing advanced life support tasks
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by providers [9-11]. Though best described during intrahospi-
tal transport of critically ill patients, non-physiologic, equip-
ment-related incidents may also pose a risk during flight [12].
The majority of data on rotary-wing transportation and adverse
events are derived from short-distance transfer of cardiac
patients, triaged during the early course of acute myocardial
infarction [13,14], as well as trauma, burn, and pediatric
cohorts [15-17]. However, the overall incidence of adverse
events during interfacility, aeromedical transport of mechani-
cally ventilated patients remains unknown [6]. Additionally,
some specialty organizations have called for the development
of a tiered, regionalized system of critical care, which poten-
tially could increase the need for interhospital transport [18]. If
a regionalized system of critical care is to be considered, it is
imperative to establish the safety of routine interfacility, aero-
medical transport. The purpose of this study was to determine
the frequency of and factors associated with adverse physio-
logic events during aeromedical transport of mechanically ven-
tilated patients during interfacility transfers to a tertiary care,
university hospital.
Materials and methods
Study design and patients
We conducted a retrospective cohort study of patients trans-
ferred to the Hospital of the University of Pennsylvania (HUP)
by rotary-wing transport from June 2001 to June 2003. The
HUP is a 685-bed, university-affiliated, tertiary care hospital
with 92 ICU beds serving the greater Philadelphia area, includ-
ing southeastern Pennsylvania and parts of Delaware, New
York, Maryland, and New Jersey. PENNstar Flight provides all
the aeromedical transport for critically ill patients transferred
from referring hospitals to the HUP. Flight crews consist of a
paramedic, nurse, pilot, and additional crew if space allows
(physician, nurse, or paramedic). No physicians were present
on flights during the study period; however, a medical com-
mand physician was available to provide consultations and
treatment guidance to referring institutions. All patients trans-
ported via PENNstar Flight from a referring hospital and admit-
ted to an HUP ICU were eligible for the study. We excluded
transports from trauma scenes, patients transferred from the
HUP to other facilities, patients referred for transfer but not
flown, and fixed-wing flights. The Investigational Review Board
of the HUP approved this research protocol with a waiver of
written informed consent.
Variables
We obtained computerized flight records from the central
PENNstar database. Discharge records from the HUP were
linked with the PENNstar dataset to determine patient out-
comes. Flight records were reviewed to abstract demographic
data, reason for transfer, initial vital signs, and ventilator set-
tings encountered by the PENNstar crew at the time of arrival
at the transferring facility. In-flight data included flight person-
nel, vital signs (documented every 5 minutes by the flight
crew), and all ventilator or airway manipulations, type and pres-
ence of intravenous access, and use of medications such as
vasopressors, sedatives, and neuromuscular blockade.
The primary outcome variable was in-flight adverse events, cat-
egorized as either major or minor. Based upon on our review
of the literature, there is no consensus or consistency in the
definitions used to describe major and minor adverse events
[7,19-21]. Thus, similar to other reports, we defined major
adverse events during interhospital transport as death, car-
diac/respiratory arrest, pneumothorax, and seizure. Minor
adverse events were defined as (a) respiratory: new arterial
oxygen saturation (SaO2) of less than 85%, decrease in SaO2
by 10%, or ventilator change during flight (including transition
to manual ventilation); (b) cardiovascular: new mean arterial
pressure of less than 60 mm Hg, new heart rate of less than
60 beats per minute, change in heart rate or mean arterial
pressure requiring medication administration, or new arrhyth-
mia; or (c) administration of sedative or neuromuscular block-
ade for a change in vital signs or ventilator dysynchrony.
Transferring hospital characteristics were obtained from the
2003 American Medical Association annual survey. Data
abstracted included hospital ownership (profit or non-profit),
community size (large urban, small urban, or rural), number of
hospital and ICU beds, and landing zone location. The time of
flight, date, duration (in minutes), and distance (in kilometers)
were also determined for each patient. Arc distances between
hospitals were calculated using the exact latitude and longi-
tude of each facility [22]. Patient outcomes, including ICU and
hospital lengths of stay, ventilator days, and discharge status,
were determined from the hospitals' administrative database in
evaluable patients.
Statistical analysis
Values are presented as mean ± standard deviation, median
(interquartile range), or frequency (percentage). Bivariate
associations between hospital and flight characteristics and
the presence of adverse events were evaluated using an
unpaired t test, the Wilcoxon rank sum test, or a chi-square
test, as appropriate. Because the small number of adverse
events limited model size and because we were not interested
in the effect of exposures independent of other variables, a
multivariate analysis was not performed. Statistical analyses
were performed using Stata 9.0 (StataCorp LP, College Sta-
tion, TX, USA). All tests were two-tailed, and a P value of 0.05
was considered significant.
Results
During the 36-month period of review, 1,120 patients were
transferred by PENNstar Flight to the HUP. One hundred
ninety-one were rotary-wing, interfacility, aeromedical trans-
ports of patients who were receiving mechanical ventilation at
the time of flight (one patient had no data available for review)
(Figure 1). Patient characteristics are shown in Table 1 and
diagnoses are presented in Table 2. Median flight distanceAvailable online http://ccforum.com/content/12/3/R71
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was 48 (31 to 83) km, with the majority of flights during day-
light hours (7 a.m. to 7 p.m.). Mode of ventilation was primarily
volume-cycled via endotracheal tube, with a large proportion
of patients receiving vasopressors (29%) and neuromuscular
blockade from the transferring hospital or flight staff prior to
flight (54%). Sixteen percent of patients had the ventilator
mode changed by flight staff prior to flight, and 17% had an
increase in fraction of inspired oxygen (median increase = 0.5
[0.4 to 0.6]). Fifty-eight hospitals transferred patients during
the period of review (Table 3). Transferring hospitals were
located primarily in large urban areas. Many hospitals did not
have a landing zone located at the hospital (51%).
Adverse events were uncommon during flight (Table 4). No
major adverse events, including death, cardiac arrest, or pneu-
mothorax, occurred during transport. Minor events were more
frequent (22% of patients), and the administration of neu-
romuscular blockade/sedation or ventilator change for an
alteration in vital signs was the most common. Administration
of beta blockers, adjustment of vasopressors, and fluid
boluses were the most common medicines administered dur-
ing flight. Table 5 shows patient and flight characteristics cat-
egorized by the presence (n = 40) or absence (n = 140) of
adverse events during flight. Only the presence of vasopres-
sors and flight distance were associated with adverse events
(P < 0.05). Vasopressor use was more common in patients
transported from transferring hospital ICUs compared with
emergency rooms (35% versus 18%; P  < 0.01). Patients'
demographics, level of ventilator support, use of manual venti-
lation, presenting vital signs, transferring hospital characteris-
tics, and season were not significantly associated with
adverse events. Quintiles of flight distance are shown in Figure
2; the incidence of adverse events is stable in the first three
quintiles and increases in the highest two quintiles.
Discussion
In this retrospective cohort study of mechanically ventilated
patients transferred to a tertiary care medical center, rotary-
wing aeromedical transport was safe, with a notable absence
of major adverse events during flight. The presence of vaso-
pressor use and longer flight distances were associated with
an increased incidence of minor physiologic adverse events.
These data are similar to findings of safety during ground
transport of severely ill patients with respiratory failure [23]
and should facilitate efforts to study systems that rely on inter-
facility transfer for regionalization of critical care [18].
A recent review of the literature emphasized the paucity of
safety data available in patients during aeromedical transport
[6]. The present cohort of intubated patients (n = 191)
exceeds the total number of previously reported cases of ven-
tilated patients undergoing interfacility, rotary-wing transfer
[6,7,17,24]. Based upon prior reports of the safety of ground
and fixed-wing transport, we hypothesized that major adverse
events would be rare. We found that minor physiologic events
occurred at a rate similar to those previously reported [7] and
that major adverse events were absent. This mirrors the
reports of others that death and cardiac arrest are uniformly
uncommon (<2%) [7,8]. Vasopressor use was found to be
associated with minor physiologic derangements, as well as a
higher level of care at the time of transfer, likely reflecting an
increased severity of illness and hemodynamic instability.
Longer flight distance was also associated with minor physio-
logic adverse events, and surprisingly, this was not present for
flight time. Both flight times and distance may increase patient
risk simply due to longer exposure to inherent flight risks or
may also be a marker of disease severity. In the absence of a
uniform measurement of severity of illness from the outside
hospitals, we were unable to assess whether patients trans-
ferred from distant hospitals were more ill. Unlike distance,
which is a fixed variable, flight time may be associated with
other unmeasured confounders such as weather and air
speed [25].
This work may have implications for future studies of regional-
ization of care for critically ill patients. Recently, a task force
comprised of the major critical care societies emphasized
regionalization as an important strategy to increase patient
access to tertiary care institutions with multidisciplinary deliv-
ery of critical care [26]. Similarly, the Prioritizing the Organiza-
tion and Management of Intensive Care Services (PrOMIS)
committee directly called for a tiered, regionalized system of
adult critical care [18]. A large component of regionalization
will be the routine transfer of critically ill, mechanically venti-
lated patients to tertiary care centers. If we are to duplicate the
successful results of the regionalized trauma system [27], crit-
Figure 1
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ical care regionalization will require accurate knowledge of the
Table 1
Patient characteristics (n = 190)
Demographics
Age, years 55 ± 16
Female gender, number (percentage) 85 (45)
Transferring hospital patient data
Glasgow Coma Scale score 5 (3–9)
Length of stay, days 1 (1–3)
Location
Intensive care unit 113 (60)
Emergency room 76 (40)
Other 1 (<1)
Vital signs
Heart rate, beats per minute 98 ± 24
Respiratory rate, breaths per minute 17 ± 5
Mean arterial pressure, mm Hg 90 ± 22
SaO2 < 90% 11 (6)
Use of neuromuscular blockers prior to flight 101 (54)
Use of sedation prior to flighta 150 (84)
Use of vasopressors prior to flight 55 (29)
Transferring hospital ventilator data
Mode
Assist control 152 (80)
Intermittent mandatory ventilation 19 (10)
Pressure support ventilation 2 (1)
Pressure control ventilation 3 (2)
Otherb 14 (7)Available online http://ccforum.com/content/12/3/R71
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Settings
Tidal volume, mL 654 ± 105
Positive end-expiratory pressure, cm H2O5 . 4  ±  4 . 7
FiO2, percentage 0.73 ± 0.27
Tracheostomy 7 (4)
Flight data
Nighttime transfer 76 (40)
Winter transfer 40 (21)
Distance, km 48 (31–83)
Flight time, minutes 13 (8–22)
In-flight ventilator data
Initial mode
Assist control 147 (77)
Intermittent mandatory ventilation 14 (7)
Manual ventilationc 25 (13)
T-piece 2 (1)
Not recorded 2 (1)
FiO2, percentage 0.84 ± 0.25
Tidal volume, mL 662 ± 124
Receiving hospital outcomesd
Duration of mechanical ventilation, days 6 (3–18)
Intensive care unit length of stay, days 11 (3–21)
Hospital length of stay, days 15 (6–31)
Hospital mortality, percentage 42 (31)
Values are presented as number (percentage), mean ± standard deviation, or median (interquartile range), as appropriate. aPre-flight sedation 
includes benzodiazepines, propofol, and opiates; data are missing for 9 patients. bIncludes airway pressure release, pressure-regulated volume 
controlled, and manual ventilation. cIncludes patients transitioned to manual ventilation during flight. dOutcome data are not available from the 
receiving hospital in 53 of 190 patients (28%). FiO2, fraction of inspired oxygen; SaO2, oxygen saturation.
Table 1 (Continued)
Patient characteristics (n = 190)Critical Care    Vol 12 No 3    Seymour et al.
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additive risk imposed during interfacility transfer and ways to
predict patients at higher risk for transfer-related
complications.
Our work has several limitations. Although 58 hospitals trans-
ferred patients, the cohort is limited to a single referral center,
where all patients were transported by the PENNstar flight
crew. Because not all technical complications (tubing, moni-
tors, oxygen supply) were recorded, our analysis is limited to
clinical events. These events were assessed in a retrospective
fashion and were limited by the accuracy of data recorded by
flight staff. As vital signs were documented in the record every
5 minutes, transient events may not have been captured. How-
ever, it is unlikely that any clinically significant event would not
be noted by the flight crew, and free text recorded by flight
staff in the flight record was also reviewed by study staff to
search for these events which may have not been obtained by
the vital sign record. Variability in the completeness of docu-
mentation of adverse events may have occurred due to differ-
ences in the flight crews; however, flight staff was composed
of similarly trained individuals on all PENNstar flights. Also, the
definitions employed for major and minor adverse events rep-
resent a consensus among investigators and recent literature,
as no professional society has established uniform guidelines
Table 2
Patient diagnoses at the time of transfer
Cardiology and cardiac surgery 45 (24)
Acute coronary syndrome without shock 9 (20)
Cardiogenic shock 20 (45)
Thoracic/abdominal aortic aneurysm 4 (9)
Post-cardiac arrest 8 (18)
Other 4 (9)
Neurological 70 (37)
Cerebral vascular accident 15 (21)
Intracerebral hemorrhage 54 (77)
Meningitis 1 (1)
Pulmonary 40 (21)
Asthma/Chronic obstructive pulmonary disease 4 (10)
Hemopytsis 3 (8)
Respiratory failure 29 (72)
Other 4 (10)
Surgical 10 (5)
Traumatic injury 8 (80)
Necrotizing fasciitis 2 (20)
Drug overdose/Poisoning 9 (5)
Gastrointestinal 9 (5)
Bleeding 4 (44)
Liver failure 5 (55)
Oncology 6 (3)
Values are presented as number (percentage)Available online http://ccforum.com/content/12/3/R71
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[7,19-21]. Discordant interpretation of various in-flight events
as 'usual care' may further reduce the incidence of adverse
events reported herein. The present cohort consists of short-
distance, aeromedical transfer of patients and may not be gen-
eralizable to fixed-wing or longer distance rotary-wing flights
(>100 km). Importantly, this cohort does not describe all
patients undergoing interfacility transfer to tertiary care cent-
ers, as a certain proportion travel via ground ambulance
[7,28]. The goal of this study was to evaluate the incidence of
adverse events in aeromedical transport patients only as they
are likely to be at the highest risk for complications. However,
these patients were stabilized prior to interhospital transport at
transferring facilities, perhaps reducing the incidence of major
adverse events. Other data not evaluated were the duration of
time during secondary ground transport in those patients
delivered to a landing zone off-site from the transferring hospi-
tal (51%). This time may be a surrogate for severity of illness
but may also represent an opportunity for equipment-related,
non-physiologic adverse events [29]. Finally, the impact these
in-flight adverse events may have on outcomes of subsequent
care at tertiary care centers is not known, and the present work
is notable for incomplete receiving hospital data. Multiple
steps in patient care occur following rotary-wing transport and
may include secondary transport to the receiving facility, re-
triage in receiving hospital emergency rooms, definitive surgi-
cal interventions, new medical complications, and/or stabiliza-
tion in destination ICUs [30]. It is established that transferred
patients have worse ICU outcomes at receiving hospitals
[2,30], and the present study was not designed to determine
whether transfer events contribute to this finding.
Conclusion
This cohort of mechanically ventilated patients undergoing
interfacility, aeromedical transport confirms prior work in criti-
cally ill patients transferred via ground ambulance that major
adverse events, including death, are rare. Minor physiologic
events occur at a rate similar to those undergoing flight while
not intubated and may be associated with concurrent use of
vasopressors and longer flight distance. Prior to adoption of
regionalized care systems, further multicenter, prospective
studies are needed with consensus definitions of adverse
events during flight and multivariate analysis of pre-flight risk
factors.
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Table 3
Transferring hospital characteristics
Total referring hospitals, number 58
Ownership
Non-profit 54 (93)
For-profit 4 (7)
Government 0 (0)
Total beds, number 300 ± 177
Intensive care unit beds, number 25 ± 14
Trauma center 14 (24)
Off-site landing zone for rotary-wing pick-upa 29 (51)
Community size
Rural 2 (4)
Small urban 21 (36)
Large urban 35 (60)
Affiliated with a medical school 27 (47)
Values are presented as number (percentage) or mean ± standard 
deviation. aData are missing for one hospital.
Figure 2
Presence of minor physiologic events during flight, stratified according  to quintile of flight distance (kilometers) Presence of minor physiologic events during flight, stratified according 
to quintile of flight distance (kilometers).
Key messages
￿  Transport of mechanically ventilated patients by rotary-
wing transport is safe.
￿  Use of vasopressors and longer transport distance may 
be associated with minor adverse physiologic events 
during flight.Critical Care    Vol 12 No 3    Seymour et al.
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Table 4
Physiologic adverse events during interfacility transport of 190 patients
Major adverse events
Death 0 (0)
Cardiovascular collapse requiring advanced cardiac life support 0 (0)
Seizure 0 (0)
Pneumothorax 0 (0)
Minor adverse eventsa
Respiratory compromise
New oxygen saturation <85% 7 (4)
Oxygen saturation decrease by >10%b 8 (4)
In-flight change in ventilator settingsc 4 (2)
Cardiovascular compromise
New mean arterial pressure <60 mm Hg 5 (3)
New heart rate <60 beats per minute 4 (2)
New arrhythmia 3 (2)
New administration of medicine for compromise of vital signsd 17 (9)
Administration of sedation/paralysis for vital sign change or ventilator dysynchrony 15 (8)
Values are presented as number (percentage). aFor 180 patients with complete physiologic data during flight. bIf normoxemic, oxygen saturation of 
greater than 90% before flight. cVentilator interventions included switching to manual ventilation or beginning inhaled prostacyclin. dIncludes new 
administration of fluid bolus, beta blockers, or titration of vasopressors.Available online http://ccforum.com/content/12/3/R71
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Table 5
Bivariate analysis of transport variables and presence of adverse eventsa
Variable Adverse event (n = 40) No adverse event (n = 140) P value
Patient characteristics
Age, years 57 ± 16 55 ± 16 0.44
Female gender 43 43 0.97
Glasgow Coma Scale score 5 (3–8) 5 (3–9) 0.57
Outside hospital length of stay, days 1 (1–2) 1 (1–3) 0.52
Pre-flight presence of vasopressors, number (percentage) 18 (45) 30 (21) <0.01
Pre-flight fraction of inspired oxygen, percentage 0.77 ± 27 0.72 ± 30 0.39
PEEP prior to flight 5 ± 5 6 ± 4 0.25
Patient in emergency room when transferred 39 37 0.84
Use of manual ventilation during flight, number (percentage) 5 (12.5) 17 (12) 1.0
Hospital characteristics
Bed size
<200 9 (26%) 38 (30%) 0.6
200–400 13 (37%) 53 (42%)
>400 13 (37%) 36 (28%)
Academic institution 15 (43%) 58 (46%) 0.77
Transfer characteristics
Landing zone on site at transferring hospital 19 (49) 61 (46) 0.75
Nighttime transfer 15 (38%) 58 (41%) 0.66
Winter transfer 6 (15%) 33 (24%) 0.25
Distance, km 57 (35–95) 47 (31–82) 0.02
Flight time, minutes 15 (10–24) 12 (8–20) 0.32
Values are presented as number (percentage), mean ± standard deviation, or median (interquartile range), as appropriate. aFor 180 patients with 
complete physiologic data during flight. PEEP, positive end-expiratory pressure.Critical Care    Vol 12 No 3    Seymour et al.
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